December 16, 2020 10:54 AM EST
News Briefing

News brief­ing: Bob Cough­lin is jump­ing in­to re­al es­tate — in a big way; Keytru­da plus Lenvi­ma posts pos­i­tive PhI­II da­ta in en­dome­tri­al can­cer

John Carroll

Editor & Founder

We know now where Mass­Bio chief Bob Cough­lin is head­ed. JLL re­ports that Cough­lin is join­ing the bro­kers hatch­ing new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times